Fox Chase Cancer Center’s Lori Goldstein Named to Forbes’ “Physician Honor Roll”

December 5, 2017

Lori J. Goldstein, MD, FASCOLori J. Goldstein, MD, FASCO

PHILADELPHIA (December 5, 2017) — Lori J. Goldstein, MD, FASCO, Deputy Associate Director of Clinical Research,  Professor of Medical Oncology and the Director of Naomi and Phil Lippincott Breast Evaluation Center at Fox Chase Cancer Center, is one of 27 breast oncologists across the country being recognized by Forbes as an exemplary physician in the field of oncology.

Individuals on the list serve in the top spots of their respective hospitals, contribute a wealth of clinical research to advance the practice, and serve on community boards and national organizations. Goldstein is a renowned leader who has made significant contributions in breast cancer care and research, both within Fox Chase and the wider field of breast cancer medicine. Throughout her career, Goldstein has been driven by a passion to improve care for breast cancer patients— helping patients make informed treatment decisions, leading nationally recognized research programs, and investigating new approaches for evaluating and treating the disease.

In addition to her clinical work treating patients, Goldstein conducts both clinical and translational research in breast cancer with the overarching goal of improving diagnostic and treatment options. In 2012 she became Deputy Associate Director for Clinical Research at Fox Chase, a role in which she supports the work of more than 100 researchers. Goldstein also is a member of the Breast Cancer Guidelines Committee for the National Comprehensive Cancer Network, an alliance of leading cancer centers.

The Forbes list was generated via a partnership with Grand Rounds, whose mission is to connect patients with the highest quality care available to them. Grand Rounds’ matching algorithm connects patients with physicians uniquely qualified to care for their specific clinical need. Grand Rounds’ algorithm includes physician quality data on 99 percent of practicing physicians in the U.S.

Forbes’s list features individual profiles of all health care leaders.

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.


For more information, call 888-369-2427

Connect with Fox Chase